Answers are grounded in this paper and cite their sources.
This historical perspective highlights the evolution of STEMI care and identifies cardiogenic shock and myocardial salvage as key remaining frontiers requiring novel therapeutic approaches.
After a brief history of the emergence of modern therapy for acute ST-elevation myocardial infarction, we discuss the issues that dominate ongoing studies and are the focus of intense debates. The role of angiography, pharmacotherapy, thrombus aspiration, management of multi-vessel disease, mechanical complications and cardiogenic shock and the quest for myocardial salvage are discussed.
No takes yet. Share an insight, caveat, or question.
Zijlstra et al. (2020) conducted a review in ST-segment elevation myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: